ARD103 CAR-T therapy

ARD103 · ARCE Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARD103 CAR-T therapy, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS [Phase 1, Phase 2]